Report shows U.S. cancer deaths on the decline
the ONA take:
According to a new report published in the Journal of the National Cancer Institute, there has been a continuing decline in cancer deaths in the United States between 2002 and 2011. During that period, the overall cancer death rate fell an average 1.5% per year for men, women, and children. Specifically, cancer death decreased 1.8% per year among men, 1.4% per year among women, and about 2% per year for children.
The report also found that the rate of new cancer cases also decreased an average 0.5% per year during those years. However, the report found that cancer rates are increasing for kidney, liver, mouth and throat, and thyroid cancer.
"These numbers reflect a combination of factors that include prevention, early detection and improved treatment," said report co-author Ahmedin Jemal, vice president of surveillance research for the American Cancer Society.
Colon and breast cancer deaths are declining due to prevention efforts, while lower rates of lung cancer deaths are due to fewer people smoking. Prostate cancer rates are also declining, but experts are not sure why.
There has been a continuing decline in cancer deaths in the United States between 2002 and 2011.
- More Than Half of Melanomas Are Self-Detected, Especially by Women
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- POLST Programs Can Benefit from the Relationship Between Patients and Nurse Practitioners
- Immune Checkpoint-Related Neurotoxicity May Be More Common During Combination Treatment
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Caregiver Mastery Linked to Patient Survival in Glioblastoma
- Treatment Facility Volume Associated With Mortality Risk in Multiple Myeloma
- Adherence to Tamoxifen, AIs Among Older Women is Low, Study Shows
- Replacing Neoadjuvant CRT with Multiagent Chemo Not Recommended for Rectal Cancer
- Study Identifies Factors Associated With Infection-related Complications in ALL
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|